Perceptions of Safety: Marijuana Smoke vs Tobacco Smoke

Aug.16.2023
Perceptions of Safety: Marijuana Smoke vs Tobacco Smoke
A recent study published in JAMA Network Open reveals that a majority of Americans believe marijuana smoke is safer than tobacco smoke.

Special statement: We would like to make it clear that the information provided in this article is trustworthy and accurate. Our team has conducted thorough research and verification to ensure the reliability of the facts presented. We aim to provide our readers with reliable news and unbiased reporting, upholding professional standards in journalism.


This article is solely intended for industry research and communication among professionals and does not involve any product evaluation or recommendation.


Please note that the items mentioned in the article may be subject to different regulatory policies in different countries and regions. Readers are advised to strictly adhere to relevant laws and regulations in China.


This article is intended for readers who are 18 years of age or older.


On August 14, according to a report by CNN, a survey from the Journal of the American Medical Association Network Open revealed that the majority of respondents (44%) believe that smoking marijuana is safer than smoking tobacco. Additionally, they also believe that the risks of inhaling secondhand marijuana smoke for both adults and children are lower than those of cigarette smoke. However, Dr. Beth Cohen, the lead author of the study and a medical professor at the University of California, San Francisco (UCSF), as well as the co-director of the UCSF Inpatient Investigative Methods and Epidemiology Program, argues that these beliefs are not accurate.


A study published in the Journal of the American Medical Association Network Open examined the growing acceptance of marijuana among a sample of over 5,000 individuals with an average age of 50. The study aimed to understand their attitudes towards the safety of marijuana use compared to tobacco use. Participants were also asked whether they believed secondhand smoke from marijuana or tobacco could be harmful.


According to a study conducted in 2017, 2020, and 2021, the positive perception of marijuana among people has been steadily increasing. By the final year of the survey in 2021, over 44% of respondents believed that marijuana was somewhat or even safer, while only 25.5% considered cigarettes to be safer.


In light of the potential harm it may cause to others (secondhand smoke), over 40% of individuals consider marijuana smoke to be safer, while only 23% opt for tobacco.


However, experts in the field do not agree with this trend. Carol Boyd, the founding director of the Center for Drug, Alcohol, Smoking, and Health Research at the University of Michigan-Ann Arbor, stated that marijuana smoke contains "a significant amount of toxins and tar," which could potentially harm the lungs.


Boyd stated:


I am unable to comment on the dangers, but if an individual is in a confined space with marijuana users, the presence of marijuana components may be detected in their urine. They may also experience other physiological effects of marijuana, including increased heart rate and a sense of excitement.


Boyd believes that comparing the health risks of consuming marijuana and tobacco is of little significance. All forms of smoking have irritating effects on the respiratory system, he commented.


In an era where humanity breathes polluted air, being smoke-free is beneficial.


Research on marijuana has been hampered by its illegal status in many states across the United States (currently still the case). Furthermore, the federal government has historically imposed strict regulations on the study of marijuana. These factors have posed significant challenges to the investigation of marijuana use.


With an increasing number of states legalizing marijuana for recreational use, researchers are now delving further into exploring the consequences of long-term cannabis consumption.


However, the current research shows that marijuana cigarettes indeed have some advantages compared to regular cigarettes, Boyd further explained.


It is commonly believed that frequent marijuana consumption is associated with chronic bronchitis, pharyngitis, and bronchial inflammation. Despite the presence of carcinogens in marijuana smoke, such as benzopyrene and benzanthracene, it seems that smoking marijuana does not appear to cause lung cancer.


In addition, individuals who consume marijuana tend to take deep breaths and hold the smoke in their lungs for extended periods of time. According to the American Lung Association, this can "result in increased exposure to tar with each breath.


Consuming marijuana can impair the lungs' first line of defense against infection, killing cells that help remove dust and bacteria, and leading to increased mucus formation.


The American Lung Association has stated that the consumption of marijuana can also suppress the immune system and potentially expose users to a particular type of mold that can grow on cannabis.


While further research is needed to understand the impact of marijuana consumption on the lungs, as well as the health effects of second-hand marijuana smoke, Cohen asserts that the current knowledge is worrisome.


She said:


I am not opposed to marijuana; I simply hope that people can make informed decisions. Even if further research indicates that marijuana smoke is relatively less harmful compared to tobacco smoke, it does not necessarily mean that it is completely safe.


Reference: [1] A recent study reveals that a significant number of Americans hold a misconception regarding the safety of marijuana smoke compared to tobacco smoke.


Title: A Comparative Analysis: Public Perceptions of the Safety of Daily Cannabis and Tobacco Smoking, along with Secondhand Smoke Exposure (2017-2021) Public opinion on the safety of daily cannabis consumption and tobacco smoking, along with the potential risks associated with secondhand smoke exposure, has been examined between the years of 2017 and 2021.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
BREAKING | China’s Tobacco Regulator Summons iMiracle Over Suspected Compliance Breaches
BREAKING | China’s Tobacco Regulator Summons iMiracle Over Suspected Compliance Breaches
Based on public records reviewed by 2Firsts, this is the first time China’s State Tobacco Monopoly Administration has publicly announced regulatory talks with an e-cigarette company.
Jul.29
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
According to CBS Los Angeles on August 27, 2026, California lawmakers have passed Assembly Bill 762, which would phase out disposable, battery-embedded nicotine vapes in the state. If signed by Governor Gavin Newsom, manufacturing and importation of the covered products would be prohibited beginning January 1, 2027, followed by a sales ban on January 1, 2028. Driven primarily by concerns over electronic waste, lithium-battery fires and environmental pollution, the legislation would further shift California’s legal vape market toward rechargeable, refillable or replaceable-pod devices.
Aug.28
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
SnowPlus has introduced a nicotine-free version of DASH in South Korea, adapting an existing overseas disposable platform for the local market. The Korean version retains the series’ flat duckbill-style mouthpiece, ceramic heating architecture and disposable form factor while reducing nicotine content to 0%. By comparison, the overseas DASH 4000 platform typically features 7.5ml of prefilled e-liquid, up to 4,000 puffs and a 530mAh rechargeable battery, with nicotine-containing variants available in some markets. The product update centers on formulation localisation rather than a new hardware generation.
Aug.31